-Blockers: "not appropriate" first-line therapy for hypertension

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1417, 2003-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spironolactone "safer first-line" therapy for hypertension

By  

Reactions Weekly, Vol. 1, Iss. 1254, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Combination Therapy as First-Line Treatment for Hypertension

By Crawford Michael H.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

ACE inhibitors not worth it as first-line therapy in hypertension

By  

Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

ACE inhibitors not worth it as first-line therapy in hypertension

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 413, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Combination therapy is preferred for the first-line treatment of hypertension in high-risk patients

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 7, 2010-07 ,pp. : 17-20

Adis International

Access to resources Recommend Favorite